Viking Therapeutics to Report Financial Results for Third Quarter 2025 on October 22, 2025

Conference Call Scheduled for Wednesday, October 22 at 4:30 p.m. Eastern Time 

SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will release financial results for the third quarter 2025 after the market close on Wednesday, October 22, 2025.

Read more at prnewswire.com